Setting new standards in information exchange for the pharmaceutical and biotech industry
Podcast: Addressing Clinical Challenges in Immuno-Oncology
December 20, 2017
Originally recorded during the 3rd annual Immuno-Oncology 360° in February 2017, this panel discussion addresses clinical challenges within immuno-oncology. One of the IO360° lead advisors, Dr James Gulley of the National Cancer Institute, moderates the session between Merck’s Dr Roy Baynes, nanoString Technologies’ Dr Alessandra Cesano, MD Anderson’s Dr Patrick Hwu, and inVentiv Health’s Robert Millham.
Save the date for the 4th annual IO360° conference, taking place February 7-9, 2018 in New York City. Dr Gulley, Dr Baynes, and Dr Cesano are returning as members of the speaking faculty.
On February 8, 2018, adjacent to IO360, there will be a full-day meeting centered on Immuno-Oncology Clinical Trials. This is the 1st full day IO trials meeting in the US, led by the most experienced clinical operation professionals executing arguably the most difficult and important trials in the history of oncology. Learn more about the meeting and see the agenda here.